AUROPHARMA.BO

AUROBINDO PHARMA LTD. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$9.16B

PE Ratio

25.23

EV to Ebitda

—

Earnings Yield

4.00%

Revenue (TTM)

$3.39B

Net Income (TTM)

$363.1M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

6.00%

Profit Margin

11.00%

Return on Equity

—

Debt to Equity Ratio

0.24

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$9.16B

Revenue TTM$3.39B

Shares Outstanding580.8M

Float281544861

Insider Ownership54.00%

Institutional Ownership30.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)6.00%

Rev Growth Est 1Y Forward0.12

EPS Growth (Quarterly YoY)4.00%

EPS Growth Est Quarterly15.89

LT EPS Growth Estimates22.00%

Operations16 fields›

Revenue TTM$3.39B

Gross Margin TTM58.00%

Gross Margin (Quarterly)60.00%

Operating Margin TTM15.00%

Operating Margin (Quarterly)15.00%

Operating Expenses TTM$42.4M

Profit Margin TTM11.00%

Profit Margin (Quarterly)11.00%

Net Income TTM$363.1M

EPS TTM58.89

EPS (Quarterly)15.67

EBITDA Margin TTM20.00%

EBITDA TTM$685.5M

Capex % of Revenue TTM0.00%

Capital Expenditures$0.00M

FCF % of Revenue (Quarterly)4.00%

Efficiency1 fields›

ROA6.00%

Valuation8 fields›

P/E (TTM)25.23

P/E Forward8.21

PEG42.18

EV/Revenues (TTM)2.56

Price To Book2.69

Price to Tangible Book3.09

Earnings Yield4.00%

Payout Ratio9.00%

Liquidity8 fields›

Current Ratio1.85

Goodwill & Intangibles$42387.20T

Total Assets$5.19B

Total Liabilities$6.80B

Shareholders Equity$3.40B

Debt to Equity0.24

Interest Expense$42.4M

Goodwill % of Assets8514056.00%

Yields2 fields›

Payout Ratio9.00%

Earnings Yield4.00%